Physician profile
Anna E Willis
NPI 1952652729
$1,305.16
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $120 · 2023: $398 · 2024: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.60 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $224.01 | 2021-2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $195.48 | 2023 | Pylarify |
| Janssen Biotech, INC. | $180.47 | 2024 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Urogen Pharma, INC. | $124.76 | 2021 | |
| Sumitomo Pharma America, INC. | $122.35 | 2023 | Orgovyx |
| Astellas Pharma US INC | $94.25 | 2022 | |
| 180 Medical, INC. | $71.54 | 2021-2024 | |
| Organogenesis INC. | $52.81 | 2023 | Puraply |
| Tolmar, INC. | $30.26 | 2024 | |
| Zimmer Biomet Holdings, INC. | $22.38 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Accord Healthcare, INC. | $18.04 | 2024 | |
| Procept Biorobotics Corporation | $16.93 | 2024 | Aquabeam System |
| Myovant Sciences INC. | $14.42 | 2021 | |
| Allergan, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.